Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)

INTRODUCTION: Progressive pulmonary fibrosis (PPF) includes any diagnosis of progressive fibrotic interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF). However, disease progression appears comparable between PPF and IPF, suggesting a similar underlying pathology relating to...

Descripción completa

Detalles Bibliográficos
Autores principales: Maher, Toby M, Assassi, Shervin, Azuma, Arata, Cottin, Vincent, Hoffmann-Vold, Anna-Maria, Kreuter, Michael, Oldham, Justin M, Richeldi, Luca, Valenzuela, Claudia, Wijsenbeek, Marlies S, Coeck, Carl, Schlecker, Christina, Voss, Florian, Wachtlin, Daniel, Martinez, Fernando J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503394/
https://www.ncbi.nlm.nih.gov/pubmed/37709661
http://dx.doi.org/10.1136/bmjresp-2022-001580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503394/
https://www.ncbi.nlm.nih.gov/pubmed/37709661
http://dx.doi.org/10.1136/bmjresp-2022-001580

Ejemplares similares